What is the current revenue of the ambulatory blood pressure monitoring devices market?

The market revenue for ambulatory blood pressure monitoring devices is anticipated at USD 1.86 billion in 2027.

How much is the ambulatory blood pressure monitoring devices industry expected to grow by 2036?

Ambulatory Blood Pressure Monitoring Devices Market size was over USD 1.7 billion in 2026 and is likely to grow at a 11.02% CAGR between 2027 and 2036, reaching USD 4.84 billion by 2036.

How is rising hypertension prevalence influencing procurement strategies in the ambulatory blood pressure monitoring devices market?

Growing hypertension cases are increasing demand for continuous blood pressure assessment, prompting hospitals, cardiology practices, and outpatient centers to expand ABPM procurement for improved diagnosis, long-term management, and higher device utilization across routine care pathways.

Why are connected ABPM devices becoming a strategic investment priority for healthcare providers?

Mobile-connected ABPM systems improve remote monitoring by simplifying data transmission, reducing manual workflows, and supporting telehealth integration, encouraging healthcare organizations to replace standalone devices with digitally connected platforms for more efficient longitudinal patient management.

Why do hospitals lead the ambulatory blood pressure monitoring devices market?

Hospitals accounted for 62.86% of the market in 2026 due to their central role in diagnosing complex hypertension cases and managing monitoring, interpretation, and follow-up within established clinical workflows.

Why is homecare becoming the fastest-growing end-use segment in the ambulatory blood pressure monitoring devices market?

Homecare is growing fastest as patients increasingly prefer convenient monitoring outside healthcare facilities, supporting routine hypertension follow-up while reducing repeat visits and improving comfort during extended monitoring periods.

Why does North America lead the ambulatory blood pressure monitoring devices market?

North America leads with 41.98% share, driven by routine hypertension screening, outpatient diagnostic integration, chronic disease management reliance, and mature device distribution supporting consistent ambulatory monitoring adoption.

How is Asia Pacific driving growth in this market?

Asia Pacific is growing at 12.99% CAGR as healthcare infrastructure improves, access expands, and outpatient monitoring adoption increases across hospitals managing rising cardiovascular patient volumes.

Which companies are driving growth in the ambulatory blood pressure monitoring devices landscape?

Major companies in the ambulatory blood pressure monitoring devices market include Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Spacelabs Healthcare, Inc. (United States), SunTech Medical, Inc. (United States), A&D Company, Limited (Japan), Microlife Corporation (Taiwan), Schiller AG (Switzerland), Hillrom Holdings, Inc. (United States), Withings (France).